Tone mix
Week by week 52 weeks
Share of Aardvark Therapeutics, Inc. Common Stock's 321 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of May 26, 2025 · tone -100Aardvark Therapeutics (NASDAQ:AARD) Rating Lowered to Sell at Wall Street Zen-120
- Week of Oct 6, 2025 · tone +99Aardvark Therapeutics Announces Fda Alignment on Protocol Amendment Expanding Phase 3 Hero Trial Population for Prader-Willi Syndrome+99
- Week of Mar 30, 2026 · tone -99Why Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings-99
- Week of Jan 19, 2026 · tone +100Aardvark Therapeutics, Inc. (NASDAQ:AARD) Given Average Recommendation of "Moderate Buy" by Brokerages+83
- Week of Apr 13, 2026 · tone -100Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- Hagens Berman-81
- Week of Apr 20, 2026 · tone -100Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- Hagens Berman-76
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Aardvark Therapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 3 | +32 |
| Last 30 sessions | 95 | -7 |
| Last 90 sessions | 228 | -15 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Tuesday, October 27, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletEquities Research Analysts' Price Target Changes for October 26th (AARD, ACG, ACR, AMR, APLE, ASIC, AXON, AXP, AXSM, BAH)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Equities Research Analysts' Price Target Changes for October 26th (AARD, ACG, ACR, AMR, APLE, ASIC, AXON, AXP, AXSM, BAH) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone +97: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletAardvark Therapeutics Clears FDA Hold on ARD-101, Eyes New Phase 3Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Aardvark Therapeutics Clears FDA Hold on ARD-101, Eyes New Phase 3 | www.tickerreport.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletAardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension TrialsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 20, 2026
2 headlines, average tone +49: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletAardvark Therapeutics (NASDAQ:AARD) Given New $4.00 Price Target at HC WainwrightPositive
- www.themarketsdaily.com · 1 outletStock Analysts' Price Target Changes for October 19th (AARD, ABX, ADC, ADNT, ANRO, APO, ARES, AVAV, BALL, BKS)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Aardvark Therapeutics (NASDAQ:AARD) Given New $4.00 Price Target at HC Wainwright | www.dailypolitical.com | 1 | Positive |
| Stock Analysts' Price Target Changes for October 19th (AARD, ABX, ADC, ADNT, ANRO, APO, ARES, AVAV, BALL, BKS) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.mykxlg.com · 1 outletAttention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Hub Group, Inc. (NASDAQ: HUBG); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your BehalfNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Hub Group, Inc. (NASDAQ: HUBG); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your Behalf | www.mykxlg.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Aardvark Therapeutics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.